Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia · Delayed Price · Currency is MYR 1.230
0.00 (0.00%)
At close: Aug 10, 2026
Duopharma Biotech Berhad Financials Overview
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 916.83 | 931.69 | 813.7 | 704.73 | 696.72 | 639.18 |
Revenue Growth | 3.78% | 14.50% | 15.46% | 1.15% | 9.00% | 12.16% |
Gross Profit Gross Profit Growth | 367.15 | 363.14 | 301.54 | 268.33 | 279.82 | 253.98 |
Operating Income Operating Income Growth | 139.62 | 133.78 | 100.26 | 78.71 | 92.91 | 88.77 |
Net Income Net Income Growth | 92.54 | 87.46 | 62.65 | 52.65 | 70.11 | 65.68 |
Earnings Per Share EPS Growth | 0.10 | 0.09 | 0.07 | 0.05 | 0.07 | 0.07 |
EPS Growth | 26.64% | 39.62% | 18.57% | -25.71% | 4.50% | 12.05% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Malaysia Malaysia Growth | 871.83 | 754.18 | 650.55 | 654.89 | 596.89 |
Export Export Growth | 59.87 | 59.51 | 54.18 | 41.83 | 42.29 |
Total Total Growth | 931.69 | 813.7 | 704.73 | 696.72 | 639.18 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 270.65 | 290.87 | 264.55 | 270.5 | 157.64 | 137.98 |
Total Debt Total Debt Growth | 484.69 | 496.08 | 515.82 | 548.85 | 431.6 | 403.84 |
Net Cash (Debt) Net Cash Growth | -214.04 | -205.21 | -251.28 | -278.35 | -273.97 | -265.86 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.22 | -0.21 | -0.26 | -0.29 | -0.29 | -0.29 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 99.06 | 106.83 | 83.34 | 48.8 | 70.27 | 43.2 |
Capital Expenditures CapEx Growth | -25.19 | -26.84 | -23.57 | -32.95 | -65.18 | -109.36 |
Free Cash Flow Free Cash Flow Growth | 73.87 | 79.99 | 59.77 | 15.86 | 5.08 | -66.16 |
Free Cash Flow Growth | -15.57% | 33.83% | 276.91% | 211.98% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.05% | 38.98% | 37.06% | 38.07% | 40.16% | 39.74% |
Operating Margin | 15.23% | 14.36% | 12.32% | 11.17% | 13.33% | 13.89% |
Pretax Margin | 13.26% | 12.33% | 9.83% | 8.98% | 12.18% | 12.98% |
Profit Margin | 10.09% | 9.39% | 7.70% | 7.47% | 10.06% | 10.28% |
FCF Margin | 8.06% | 8.59% | 7.35% | 2.25% | 0.73% | -10.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.045 | 0.045 | 0.030 | 0.023 | 0.023 | 0.022 |
Dividend Per Share Growth | 51.67% | 51.67% | 30.44% | 0% | 5.75% | -55.43% |
Dividend Yield | 3.70% | 3.72% | 2.52% | 1.96% | 1.56% | 1.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.80 | 13.75 | 19.19 | 23.02 | 21.87 | 24.09 |
Forward PE | 11.76 | 12.08 | 14.74 | 14.77 | 15.91 | 20.97 |
P/FCF Ratio | 16.02 | 15.03 | 20.12 | 76.43 | 301.61 | - |
PS Ratio | 1.29 | 1.29 | 1.48 | 1.72 | 2.20 | 2.48 |